Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

WHAT'S NEW

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jan 8 2018

Full Issue

HHS Nominee Talks Tough Against Pharma's Profit Tactics, But History At Drugmaker Tells Different Story

Alex Azar, the Trump administration's pick to head the Department of Health and Human Services, is set to testify before the Senate Finance Committee this week, where it's likely his close ties to the pharmaceutical industry will take center stage with his critics.

Politico: How Trump’s HHS Nominee’s Drug Company ‘Gamed’ Patent

When Donald Trump’s nominee for HHS secretary was a top executive at Eli Lilly, the patent on its blockbuster Cialis was soon to expire. So Lilly tested it on kids. The drugmaker believed the erectile dysfunction drug might help a rare and deadly muscle-wasting disease that afflicts boys. The drug didn’t work — but under a law that promotes pediatric research, Lilly was able to extend the Cialis patent anyway for six months — and that’s worth a lot when a medication brings in over $2 billion a year. (Karlin-Smith, 1/8)

Modern Healthcare: Senate Finance Committee Set To Hear From HHS Nominee; Health Committee To Focus On Opioid Crisis 

More than six weeks after his nomination, HHS Secretary-designate Alex Azar will receive his official confirmation hearing with the Senate Finance Committee Tuesday morning. The Jan. 9 hearing follows his Nov. 29 courtesy hearing with the Senate Health, Education, Labor and Pensions Committee. It falls to the Finance Committee, however, to hold the actual vote to advance Azar's nomination to the Senate floor. President Donald Trump also had to renominate Azar because the original nomination expired at the end of 2017. In the flurry of end-of-year business that included passage of the GOP's tax overhaul and negotiations on a short-term spending bill, the Finance Committee punted its proceedings to the new year. (Luthi, 1/6)

Meanwhile —

Roll Call: HHS Political Appointees’ Résumés Show Ties to Price, Pence

Political appointees at the Department of Health and Human Services include at least 16 staffers with ties to former Secretary Tom Price and at least 12 with connections to Vice President Mike Pence or Indiana, a review of 129 résumés of appointed staffers in the department shows. Pence’s influence over the agency can be seen in the appointment of Centers for Medicare and Medicaid Services Administrator Seema Verma, who worked closely with the former Indiana governor to expand Medicaid in that state, and the appointment of Verma’s deputy Brian Neale, who currently oversees Medicaid and served as Pence’s health care policy director in Indiana. A number of staffers also have ties to conservative groups close to Pence, such as the Heritage Foundation and anti-abortion organizations. (Clason, 1/8)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF